Ernexa Therapeutics Inc. Other Non-Current Liabilities
Ernexa Therapeutics Inc. (ERNA) had Other Non-Current Liabilities of $1.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Noncurrent $1.00K.
- 2026-03-31: Other Liabilities, Noncurrent $1.00K.
- 2025-12-31: Other Liabilities, Noncurrent $43.00K.
- 2025-09-30: Other Liabilities, Noncurrent $112.00K.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.00K 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $43.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $112.00K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $113.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $111.00K 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $111.00K 10-K · filed 2026-03-13 | |
| 2024-09-30 | $84.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $84.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $84.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $84.00K 10-K · filed 2025-03-12 | |
| 2023-03-31 | $87.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $94.00K 10-Q · filed 2023-05-11 | |
| 2022-09-30 | $1.69M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $48.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $48.00K 10-Q · filed 2022-07-01 | |
| 2021-12-31 | $48.00K 10-K · filed 2023-03-20 | $23.00K 10-K · filed 2022-04-15 |
| 2021-09-30 | $22.86K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $22.86K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $22.86K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $23.00K 10-K/A · filed 2022-07-01 | $22.86K 10-Q · filed 2021-05-17 |
| 2020-06-30 | $11.00K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $15.00K 10-Q · filed 2020-05-20 | |
| 2019-12-31 | $26.00K 10-K · filed 2021-03-11 | |
| 2019-09-30 | $25.00K 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $25.00K 10-Q · filed 2019-08-12 | |
| 2018-09-30 | $50.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $48.00K 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $50.00K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $52.00K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $18.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $15.00K 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $13.00K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $12.00K 10-K · filed 2018-03-09 | |
| 2016-09-30 | $4.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $4.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $3.00K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-09 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $2.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $1.00K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $7.00K 10-K · filed 2016-03-15 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-27 | |
| 2013-09-30 | $329.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $233.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $157.00K 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $141.00K 10-K · filed 2014-03-31 | $170.00K 10-K · filed 2013-03-29 |
| 2012-09-30 | $269.00K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $279.00K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $290.00K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $323.00K 10-K · filed 2013-03-29 | |
| 2011-09-30 | $112.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $31.00K 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $99.00K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |